S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NASDAQ:AXLA

Axcella Health (AXLA) News Today

Notice: Trading of Axcella Health halted at 12:21 PM EST due to "LULD pause".
$10.35
+0.75 (+7.81%)
(As of 09/22/2023 ET)
Compare
Today's Range
$9.26
▼
$13.32
50-Day Range
$0.60
▼
$29.75
52-Week Range
$2.59
▼
$49.25
Volume
1.01 million shs
Average Volume
307,311 shs
Market Capitalization
$30.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$131.25
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logo
marketbeat.com - September 22 at 12:34 PM
marketbeat.com logo
marketbeat.com - September 22 at 12:22 PM
MarketBeat logoAxcella Health Stock Set to Reverse Split on Tuesday, September 19th (NASDAQ:AXLA)
americanbankingnews.com - September 17 at 1:42 AM
finance.yahoo.com logoAre Medical Stocks Lagging Axcella Health (AXLA) This Year?
finance.yahoo.com - September 15 at 1:00 PM
finance.yahoo.com logoAre Medical Stocks Lagging Axcella Health (AXLA) This Year?
finance.yahoo.com - September 15 at 1:00 PM
investorplace.com logoWhy Is Axcella Health (AXLA) Stock Down 24% Today?
investorplace.com - September 15 at 10:01 AM
msn.com logoFord, GM shares fall on strike action, with ARM stock jumping post IPO and other shares on the move
msn.com - September 15 at 7:59 AM
finance.yahoo.com logoAxcella Announces Reverse Stock Split Effective September 19, 2023
finance.yahoo.com - September 14 at 8:19 PM
benzinga.com logoPenny Stocks Stocks Poised To Pop On News (EPAZ, AXLA, NVOS, IQST)
benzinga.com - September 5 at 6:34 AM
finance.yahoo.com logoAre Medical Stocks Lagging Clover Health Investments (CLOV) This Year?
finance.yahoo.com - August 30 at 11:52 AM
benzinga.com logoWhat's Going On With Axcella Health Stock This Week?
benzinga.com - August 30 at 11:52 AM
finance.yahoo.com logoAxcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug
finance.yahoo.com - August 30 at 11:52 AM
finance.yahoo.com logoAre Medical Stocks Lagging Clover Health Investments (CLOV) This Year?
finance.yahoo.com - August 30 at 11:52 AM
benzinga.com logoAxcella Health Stock Is Skyrocketing: What's Going On?
benzinga.com - August 29 at 2:14 PM
proactiveinvestors.com logoAxcella Health stock rockets on long Covid patent win
proactiveinvestors.com - August 29 at 2:14 PM
finance.yahoo.com logoAxcella Granted Patent for Long COVID Fatigue Treatment
finance.yahoo.com - August 29 at 2:14 PM
investorplace.com logoWhy Is Axcella Health (AXLA) Stock Up 280% Today?
investorplace.com - August 29 at 2:03 PM
markets.businessinsider.com logoAxcella Health (AXLA) Gets a Hold from H.C. Wainwright
markets.businessinsider.com - May 8 at 7:57 AM
finance.yahoo.com logoAxcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023
finance.yahoo.com - April 17 at 12:00 PM
finance.yahoo.com logoBig Bank's Big Q1 Performance, Florida Gov. Quietly Slips 6-Week Abortion Ban Into Law, Subway Sandwich Seeks $10B Sale: Today's Top Stories
finance.yahoo.com - April 14 at 4:09 PM
msn.com logoLong COVID-Fatigue Impacts 50M People - Axcella Health Seeks Funding To Support Drug Development
msn.com - April 14 at 11:02 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Hold Rating on Axcella Health (AXLA)
markets.businessinsider.com - April 3 at 7:44 AM
benzinga.com logoAxcella Health Q4 EPS $(0.33) Misses $(0.30) Estimate; Cash & Cash Equivalents Of Sufficient To Operate Into Q2 Of 2023
benzinga.com - April 1 at 1:41 PM
benzinga.com logoAxcella Health shares are trading higher after the company reported Q4 financial results.
benzinga.com - March 30 at 6:23 PM
finance.yahoo.com logoAxcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
finance.yahoo.com - March 30 at 8:23 AM
markets.businessinsider.com logoNoble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
markets.businessinsider.com - February 16 at 1:00 PM
msn.com logoWhy Is Axcella Health (AXLA) Stock Up 35% Today?
msn.com - February 16 at 7:59 AM
finance.yahoo.com logoAxcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
finance.yahoo.com - February 15 at 8:22 PM
finance.yahoo.com logoAxcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma Conference
finance.yahoo.com - February 9 at 8:29 PM
finance.yahoo.com logoWith lean staff, low cash, Axcella races ahead with Long Covid drug
finance.yahoo.com - January 25 at 8:31 AM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Hold Rating on Axcella Health (AXLA)
markets.businessinsider.com - January 24 at 9:51 AM
investorplace.com logoWhy Is Axcella Health (AXLA) Stock Up 66% Today?
investorplace.com - January 24 at 8:54 AM
marketwatch.com logoAxcella Health Shares Surge 53% on U.K. Regulator Guidance on AXA1125 for Long Covid Fatigue
marketwatch.com - January 23 at 7:36 PM
finance.yahoo.com logoAxcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
finance.yahoo.com - January 23 at 7:36 PM
finance.yahoo.com logoAxcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85%
finance.yahoo.com - December 23 at 8:38 AM
finance.yahoo.com logoAxcella Announces Program Reprioritization and Corporate Restructuring
finance.yahoo.com - December 15 at 12:55 AM
finance.yahoo.com logoAxcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
finance.yahoo.com - November 11 at 11:01 AM
markets.businessinsider.com logoSVB Securities Keeps Their Buy Rating on Axcella Health (AXLA)
markets.businessinsider.com - November 4 at 4:25 PM
finance.yahoo.com logoAxcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
finance.yahoo.com - November 3 at 1:27 PM
msn.com logoRecap: Axcella Health Q3 Earnings
msn.com - November 1 at 11:40 AM
finance.yahoo.com logoAxcella Reports Third Quarter Financial Results and Provides Business Update
finance.yahoo.com - November 1 at 11:40 AM
finance.yahoo.com logoAxcella Therapeutics to Report Third Quarter 2022 Financial Results on November 1, 2022
finance.yahoo.com - October 27 at 1:27 PM
insidermonkey.com logoHedge Fund and Insider Trading News: David Einhorn, Two Sigma Advisors, Starboard Value, Bireme Capital, Cohen & Steers Real Opportunities and Income Fund (RLTY), Axcella Health Inc. (AXLA), and More
insidermonkey.com - October 21 at 4:00 PM
seekingalpha.com logoAXLA Axcella Health Inc.
seekingalpha.com - October 21 at 2:39 AM
finance.yahoo.com logoAxcella Therapeutics to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
finance.yahoo.com - October 14 at 2:22 PM
finance.yahoo.com logoAxcella Therapeutics Announces $34.2 Million Registered Direct Offering of Common Stock Priced At The Market: Appoints Two New Board Members
finance.yahoo.com - October 13 at 12:45 PM
msn.com logoLooking Into Axcella Health's Recent Short Interest
msn.com - October 5 at 2:37 PM
nasdaq.com logoAxcella Reports Encouraging Interim Data From EMMPACT Study Of AXA1125
nasdaq.com - September 29 at 12:34 PM
seekingalpha.com logoAxcella adds 20% as mid-stage trial indicates potential of NASH therapy
seekingalpha.com - September 29 at 12:34 PM
finance.yahoo.com logoAxcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
finance.yahoo.com - September 29 at 12:34 PM
Get Axcella Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.



AXLA Media Mentions By Week

AXLA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AXLA
News Sentiment
▼
-0.56

0.54
▲
Average
Medical
News Sentiment

AXLA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AXLA Articles
This Week
▼
3

1
▲
AXLA Articles
Average Week

Get Axcella Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AXLA) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -